Evidence for association between genetic variants of p75 neurotrophin receptor (p75NTR) gene and antidepressant treatment response in Chinese major depressive disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 5, 2008, Pages 594-599

  Gau, Yung Tian A ^a   Liou, Ying Jay ^a,b,c   Yu, Younger W Y ^d   Chen, Tai Jui ^e   Lin, Ming Wei ^a   Tsai, Shih Jen ^a,f   Hong, Chen Jee ^a,f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b YULI VETERANS HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d Yu's Psychiatric Clinic   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Major depressive disorder; p75 neurotrophin receptor; Pharmacogenetics; Polymorphisms

Indexed keywords

CITALOPRAM; FLUOXETINE; NEUROTROPHIN RECEPTOR P75;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAMILTON SCALE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHENOTYPE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, NERVE GROWTH FACTOR; SEROTONIN UPTAKE INHIBITORS; VARIATION (GENETICS);

EID: 46949110138     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30646     Document Type: Article

References (36)

1. Alexopoulos GS, Kanellopoulos D, Murphy C, Murphy C, Gunning-Dixon F, Katz R, Heo M. 2007. Placebo response and antidepressant response. Am J Geriatr Psychiatry 15:149-158.
2. Angst J. 1992. Epidemiology of depression. Psychopharmacology 106(Suppl):S71-S74.
3. Aydemir O, Deveci A, Taneli F. 2005. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 29:261-265.
4. Burke WJ, Hendricks SE, McArthur-Campbell D, Jacques D, Stull T. 1996. Fluoxetine and norfluoxetine serum concentrations and clinical response in weekly versus daily dosing. Psychopharmacol Bull 32: 27-32.
5. Chao MV, Bothwell M. 2002. Neurotrophins: To cleave or not to cleave. Neuron 33:9-12.
6. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-265.
7. Detera-Wadleigh SD, McMahon FJ. 2004. Genetic association studies in mood disorders: Issues and promise. Int Rev Psychiatry 16:301-310.
8. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB. 2000. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97:10483-10488.
9. Duman RS. 2005. Neurotrophic factors and regulation of mood: Role of exercise, diet and metabolism. Neurobiol Aging 26(Suppl 1):88-93.
10. Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127.
11. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
12. Ebmeier KP, Donaghey C, Steele JD. 2006. Recent developments and current controversies in depression. Lancet 367:153-167.
13. Fava M. 2000. Management of nonresponse and intolerance: Switching strategies. J Clin Psychiatry 61(Suppl 2):10-12.
14. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. 2005. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255:381-386.
15. Grob PM, Ross AH, Koprowski H, Bothwell M. 1985. Characterization of the human melanoma nerve growth factor receptor. J Biol Chem 260:8044-8049.
16. Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296.
17. Hempstead BL. 2006. Dissecting the diverse actions of pro- and mature neurotrophins. Curr Alzheimer Res 3:19-24.
18. Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M. 2006. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9:1134-1141.
19. Hirschhorn JN, Daly MJ. 2005. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6:95-108.
20. Kaplan DR, Miller FD. 2000. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381-391.
21. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. 2002. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143-148.
22. Kempermann G, Kronenberg G. 2003. Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 54:499-503.
23. Kong H, Kim AH, Orlinick JR, Chao MV. 1999. A comparison of the cytoplasmic domains of the Fas receptor and the p75 neurotrophin receptor. Cell Death Differ 6:1133-1142.
24. Kunugi H, Hashimoto R, Yoshida M, Tatsumi M, Kamijima K. 2004. A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide. Am J Med Genet Part B 129B:44-46.
25. Large TH, Weskamp G, Helder JC, Radeke MJ, Misko TP, Shooter EM, Reichardt LF. 1989. Structure and developmental expression of the nerve growth factor receptor in the chicken central nervous system. Neuron 2:1123-1134.
26. Lu B, Pang PT, Woo NH. 2005. The yin and yang of neurotrophin action. Nat Rev Neurosci 6:603-614.
27. Nibuya M, Morinobu S, Duman RS. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
28. Risch N, Teng J. 1998. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res 1998. 8:1273-1288.
29. Russo-Neustadt A, Beard RC, Cotman CW. 1999. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21:679-682.
30. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M. 2003. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75.
31. Shirayama Y, Chen AC, NakagawaS, Russell DS, Duman RS. 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261.
32. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM. 1997. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137.
33. Smith MA, Makino S, Kvetnansky R, Post RM. 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15(3 Pt 1):1768-1777.
34. Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B. 2006. Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry 67:1741-1746.
35. Taniuchi M, Johnson EM, Roach PJ, Lawrence JC. 1986. Phosphorylation of nerve growth factor receptor proteins in sympathetic neurons and PC12 cells. In vitro phosphorylation by the cAMP-independent protein kinase FA/GSK-3. J Biol Chem 261:13342-13349.
36. Tsai SJ, Hong CJ, Cheng CY, Liao DL, Liou YJ. 2007. Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia. J Neural Transm 114:423-426.